CureVac - Ingmar Hoerr, CEO

1,219 वेळा पाहिले
8.1
धन्यवाद, तुमचा मत नोंदवला गेला आहे आणि तो लवकरच प्रदर्शित केला जाईल.
हो
नाही
तुमच्या प्रोफाइल बुकमार्कमध्ये जोडले.
व्हिडिओचे वर्णन

CureVac, a clinical stage biopharmaceutical company from Tübingen, Germany, is pioneering the field of mRNA-based technology platforms for medical purposes with which mRNA is specifically optimised and formulated. Since 2000 the company develops novel mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases – both under the brand RNActive®. CureVac has successfully established the first GMP (good manufacturing practice) facility worldwide for the manufacture of RNA and mRNA and has pioneered mRNA-based drugs in clinical studies.

टिप्पण्या